Subscribe to the Journal

Psychiatrist.com Home          Keyword Search

Close [X]

Search Our Sites

Enter search terms below (keywords, titles, authors, or subjects). Then select a category to search and press the Search button. All words are assumed to be required. To search for an exact phrase, put it in quotes. To exclude a term, precede it with a minus sign (-).

Keyword search:

Choose a category:

Choosing the appropriate category will greatly improve your chances of finding the best match.

All files at our sites: J Clin Psychiatry, Primary Care Companion, CME Institute, and MedFair

Search materials from our journals:

Abstracts from The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements

PDFs of the full text of The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements (paid subscribers)

PDFs of the full text of The Primary Care Companion, 1999–present

Search CME offerings:

CME Institute, including CME from journals , supplements, and Web activities for instant CME credit (registered users); also includes information about our CME program

CME activities from regular issues of The Journal of Clinical Psychiatry (registered users)

CME Supplements from The Journal of Clinical Psychiatry (registered users)

American Society of Clinical Psychopharmacology

The Journal of Clinical Psychiatryis the official journal of the American Society of Clinical Psychopharmacology (ASCP). Each month, the ASCP contributes "ASCP Corner" to the Journal. The Corner contains short evidence-based discussions on clinical psychopharmacology and periodically contains news of the Society and announcements of Society meetings and activities.

Available ASCP Corners

2014

Inflammatory Depression: A Trifecta of Trouble

Charles L. Raison

[Purchase] [Full Text]

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

Maurizio Fava

[Purchase] [Full Text]

The ASCP Annual Meeting (NCDEU): A History [FREE ACCESS]

Maurizio Fava

[Full Text]

2013

The Role of Vitamin D in Depression: From a Curious Idea to a Therapeutic Option

Cédric Annweiler, Reza Rastmanesh, Stéphane Richard-Devantoy, and Olivier Beauchet

[Purchase] [Full Text]

Decision Making and Antipsychotic Medication Treatment for Youth With Autism Spectrum Disorders: Applying Guidelines in the Real World

Stephanie H. Ameis, Patricia Corbett-Dick, Lynn Cole, and Christoph U. Correll

[Purchase] [Full Text]

Antidepressant Use in Pregnancy and Risk of Autism Spectrum Disorders: A Critical Examination of the Evidence

Chittaranjan Andrade

[Purchase] [Full Text]

Pulsed Intravenous Administration of Scopolamine Produces Rapid Antidepressant Effects and Modest Side Effects

Maura L. Furey and Carlos A. Zarate, Jr

[Purchase] [Full Text]

Changes in the Diagnostic Criteria for Autism in DSM-5: Controversies and Concerns

Eric P. Hazen, Christopher J. McDougle, and Fred R. Volkmar

[Purchase] [Full Text]

Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder Comorbidity in Children and Adolescents: Evidence-Based Approach to Diagnosis and Treatment

Shefali Miller, Kiki D. Chang, and Terence A. Ketter

[Purchase] [Full Text]

Current Status of Ketamine and Related Compounds for Depression

Daniel C. Mathews and Carlos A. Zarate, Jr

[Purchase] [Full Text]

Lessons Learned From d-Cycloserine: The Promise and Limits of Drug Facilitation of Exposure Therapy

Thomas L. Rodebaugh and Eric J. Lenze

[Purchase] [Full Text]

Reconsidering Chronic Hyponatremia in Psychosis

Richard C. Josiassen, Dawn M. Filmyer, Alexander G. Geboy, and Rita A. Shaughnessy

[Purchase] [Full Text]

Monoamine Oxidase Inhibitors Revisited:What You Should Know

Joseph F. Goldberg and Michael E. Thase

[Purchase] [Full Text]

2012

Cardiovascular Disease and Bipolar Disorder:Risk and Clinical Implications

Holly A. Swartz and Andrea Fagiolini

[Purchase] [Full Text]

Discordance Between Researchers and Patients in Defining Remission From Depression

Mark Zimmerman

[Purchase] [Full Text]

2011

Stepping Back to Step Forward: Lessons From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Amy T. Peters and Andrew A. Nierenberg

[Purchase] [Full Text]

Assessing the Adequacy of Past Antidepressant Trials: A Clinician’s Guide to the Antidepressant Treatment Response Questionnaire

Martin Desseilles, Janet Witte, Trina E. Chang, Nadia Iovieno, Christina M. Dording, Heidi Ashih, Maren Nyer, Marlene P. Freeman, Maurizio Fava, and David Mischoulon

[Purchase] [Full Text]

Rediscovering Adverse Anticholinergic Effects

Philip Gerretsen and Bruce G. Pollock

[Purchase] [Full Text]

Number Needed to Treat: What It Is and What It Isn’t, and Why Every Clinician Should Know How to Calculate It

Leslie Citrome

[Purchase] [Full Text]

Omega-3 Fatty Acids and Depression: From Cellular Mechanisms to Clinical Care

Marlene P. Freeman and Mark H. Rapaport

[Purchase] [Full Text]

2010

New Antipsychotic Drugs: How Do Their Receptor-Binding Profiles Compare?

Elliott Richelson

[Purchase] [Full Text]

Bereavement, Complicated Grief, and DSM, Part 2: Complicated Grief

Sidney Zisook, Naomi M. Simon, Charles F. Reynolds III, Ronald Pies, Barry Lebowitz, Ilanit Tal Young, Jennifer Madowitz, and M. Katherine Shear

[Purchase] [Full Text]

Bereavement, Complicated Grief, and DSM, Part 1: Depression

Sidney Zisook, Charles F. Reynolds III, Ronald Pies, Naomi Simon, Barry Lebowitz, Jen Madowitz, Ilanit Tal-Young, and M. Katherine Shear

[Purchase] [Full Text]

Therapeutic Drug Monitoring in Pregnant and Postpartum Women: Recommendations for SSRIs, Lamotrigine, and Lithium

Kristina M. Deligiannidis

[Purchase] [Full Text]

Transcranial Magnetic Stimulation for Medication-Resistant Depression

Agustin G. Yip and Linda L. Carpenter

[Purchase] [Full Text]

How to Efficiently Maintain Your Own Electronic Resource Library

Leslie Citrome and Stuart V. Moss

[Purchase] [Full Text]

2009

Reconceptualizing Medication Management: Implications for Training and Clinical Practice

John Q. Young and J. Craig Nelson

[Purchase] [Full Text]

Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 2

Gerard Sanacora

[Purchase] [Full Text]

Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 1

Gerard Sanacora

[Purchase] [Full Text]

Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 2

Holly A. Garriock and Steven P. Hamilton

[Purchase] [Full Text]

Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 1

Holly A. Garriock and Steven P. Hamilton

[Purchase] [Full Text]

Suicide Risk and Psychopharmacology: Assessment and Management of Acute and Chronic Risk Factors

Scott A. Freeman

[PDF]

Adding Lithium or Anticonvulsants to Antipsychotics for the Treatment of Schizophrenia: Useful Strategy or Exercise in Futility?

Leslie Citrome

[PDF]

Second-Generation Antipsychotic-Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need

Dan Cohen and Christoph U. Correll

[PDF]

All Antipsychotics Are Equal, but Some Are More Equal Than Others

Jan Volavka, and Leslie Citrome

[PDF]

Breast Feeding and Antidepressants: Clinical Dilemmas and Expert Perspectives.

Marlene P. Freeman, M.D.

[PDF]

Why Aren't MAOIs Used More Often?

Jan Fawcett

[PDF]

2008

Is the Problem of a High Placebo Response Unique to Antidepressant Trials?

Arif Khan and Amritha Bhat

[PDF]

Qualifications for Recertification: An Important but Evolving Set of Standards.

Mark Hyman Rapaport, and Deborah J. Hales

[PDF]

Commentary.

Victor I. Reus

[PDF]

The Search for Knowledge: Developing the American Psychiatric Association's Practice Guideline for Major Depressive Disorder.

Alan J. Gelenberg

[PDF]

Are Nutritional Supplements Ready for Prime Time?

David Mischoulon and Maurizio Fava

[PDF]

Are Antidepressants Effective? What’s a Clinician to Think?

J. Craig Nelson, Michael E. Thase, and Arif Khan

[PDF]

Antipsychotic Polypharmacy, Part 2: Why Use 2 Antipsychotics When 1 Is Not Good Enough?

Christoph U. Correll

[PDF]

Antipsychotic Polypharmacy, Part 1: Shotgun Approach or Targeted Cotreatment?

Christoph U. Correll

[PDF]

What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 2: Complex Presentations and Clinical Context

Joseph F. Goldberg

[PDF]

Balancing Risks: Dosing Strategies for Antidepressants Near the End of Pregnancy

Laura J. Miller, Jeffrey R. Bishop, James H. Fischer, Stacie E. Geller, and Carol Macmillan

[PDF]

State of the Society.

[PDF]

2007

What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 1: First-Line Treatments.

Joseph F. Goldberg

[PDF]

Teaching and Practicing Psychopharmacology

John M. Kane

[PDF]

Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 2: Methodological Considerations

Worried Sick: Antidepressants, Stress, and Inflammation

R.Bruce Lydiard, Ph.D., M.D.

[PDF]

Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 2: Methodological Considerations

Christoph U. Correll, M.D.

[PDF]

Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 1: Challenges and Developments

Christoph U. Correll, M.D.

[PDF]

Dual Dependency on Cocaine and Alcohol in Opiate Addicts: Treatment Options

Tracie Gardner, Ph.D., and Thomas Kosten, M.D.

[PDF]

Pharmacoepidemiology: Recent Findings and Challenges for Child and Adolescent Psychopharmacology

Julie Magno Zito, Ph.D.

[PDF]

Psychopharmacology in the Emergency Room

Michael D. Jibson, M.D., Ph.D.

[PDF]

Psychopharmacologic Treatment Response of HIV-Infected Patients to Antipsychotic Medications

Dinesh Singh, M.B.Ch.B., M.Med. (Psych), F.C.Psych.; and Karl Goodkin, M.D., Ph.D., F.A.P.A.

[PDF]

Choice of Antipsychotic in HIV-Infected Patients

Dinesh Singh, M.B.Ch.B., M.Med. (Psych),F.C.Psych.; and Karl Goodkin, M.D., Ph. D., F.A.P.A.

[PDF]

The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long Term Treatement

Leslie Citrome, M.D., M.P.H.

[PDF]

The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 1: Acute Treatement

Leslie Citrome, M.D., M.P.H.

[PDF]

2006

Primary Care Pitfalls for the Psychiatrist Psychopharmacologist

James W. Thompson, M.D., M.P.H.

[PDF]

Measurement-Based Psychiatry: Definitions of Response, Remission, Stability, and Relapse in Schizophrenia

Stefan Leucht, M.D., and John M. Kane, M.D.

[PDF]

Combining Pharmacotherapy With Psychotherapeutic Management: Guidelines for Integration

Ira D. Glick, M.D.

[PDF]

Buprenorphine: Reflections of an Addictions Psychiatrist

Jeffrey Selzer, M.D.

[PDF]

FDA Post-Marketing Safety Decisions

Donald F. Klein, M.D.

[PDF]

ASCP Administers 10th Certification Exam

ASCP Examination Committee

[PDF]

Female Sexual Dysfunctions: What Controversy?

Anita H. Clayton, M.D.

[PDF]

Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

John M. Kane, M.D.

[PDF]

Novel Transdermal Delivery Formulation of the Monoamine Oxidase Inhibitor Selegiline Nearing Release for Treatment of Depression

Michael E. Thase, M.D.

[PDF]

Use of Atypical Antipsychotics: Observations From Clinical Practice

Scott A. Spier, M.D.

[PDF]

Complex Chemical Concoctions

James W. Jefferson, M.D.

[PDF]

Real-Life Switching Strategies With Second-Generation Antipsychotics

Christoph U. Correll, M.D.

[PDF]

2005

Real-Life Dosing With Second-Generation Antipsychotics

Christoph U. Correll, M.D.

[PDF]

Sexual Function and Dysfunction During Treatment With Psychotropic Medications

Richard Balon, M.D.

[PDF]

Metabolic Side Effects of Second-Generation Antipsychotics in Children and Adolescents: A Different Story?

Christoph U. Correll, M.D.

[PDF]

Gender Differences in Clinical Psychopharmacology

Anita H. Clayton, M.D.

[PDF]

Increased Risk of Cerebrovascular Adverse Events and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: What’s a Clinician to Do?

J. Craig Nelson, M.D.

[PDF]

Challenges and Opportunities in Teaching Psychopharmacology During Residency Training

Sidney Zisook, M.D.; Ira Glick, M.D.; and David A. Goldberg, M.D.

[PDF]

Cultural Competence in Clinical Psychopharmacology

James W. Thompson, M.D., M.P.H.

[PDF]

Reading Reports of Clinical Trial Results

John M. Kane, M.D.

[PDF]

From the President

John M. Kane, M.D.

[PDF]